Skip to main content

Remicade Sales Data

Rank 8 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Remicade U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 8 -2.71% -4.85%
Q3 2013 8 2.60% 2.42%
Q2 2013 8 2.76% 1.19%
Q1 2013 8 3.58% 2.51%
Q4 2012 8 -1.73% -4.32%
Q3 2012 8 (2) 2.02% 1.76%
Q2 2012 10 (1) 3.76% 2.38%
Q1 2012 11 (2) 10.04% 10.04%
Q4 2011 13 (3) -7.02% -9.82%
Q3 2011 10 1.52% 1.03%
Q2 2011 10 (2) 7.61% 7.11%
Q1 2011 12 n/a n/a

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.